» Articles » PMID: 23158935

Hydrogels Derived from Central Nervous System Extracellular Matrix

Abstract

Biologic scaffolds composed of extracellular matrix (ECM) are commonly used repair devices in preclinical and clinical settings; however the use of these scaffolds for peripheral and central nervous system (CNS) repair has been limited. Biologic scaffolds developed from brain and spinal cord tissue have recently been described, yet the conformation of the harvested ECM limits therapeutic utility. An injectable CNS-ECM derived hydrogel capable of in vivo polymerization and conformation to irregular lesion geometries may aid in tissue reconstruction efforts following complex neurologic trauma. The objectives of the present study were to develop hydrogel forms of brain and spinal cord ECM and compare the resulting biochemical composition, mechanical properties, and neurotrophic potential of a brain derived cell line to a non-CNS-ECM hydrogel, urinary bladder matrix. Results showed distinct differences between compositions of brain ECM, spinal cord ECM, and urinary bladder matrix. The rheologic modulus of spinal cord ECM hydrogel was greater than that of brain ECM and urinary bladder matrix. All ECMs increased the number of cells expressing neurites, but only brain ECM increased neurite length, suggesting a possible tissue-specific effect. All hydrogels promoted three-dimensional uni- or bi-polar neurite outgrowth following 7 days in culture. These results suggest that CNS-ECM hydrogels may provide supportive scaffolding to promote in vivo axonal repair.

Citing Articles

Investigation of neuro-regenerative therapeutic potential of nerve composite matrix hydrogels embedded with adipose-derived stem cells.

Baek I, Song Y Matrix Biol Plus. 2024; 24:100165.

PMID: 39633894 PMC: 11616072. DOI: 10.1016/j.mbplus.2024.100165.


Preparation and characterization of bovine dental pulp-derived extracellular matrix hydrogel for regenerative endodontic applications: an in vitro study.

Elnawam H, Thabet A, Mobarak A, Abdallah A, ElBackly R BMC Oral Health. 2024; 24(1):1281.

PMID: 39448989 PMC: 11515367. DOI: 10.1186/s12903-024-05004-z.


Development of Tissue-Engineered Model of Fibrotic Scarring after Spinal Cord Injury to Study Astrocyte Activation and Neurite Outgrowth In Vitro.

Ala-Kokko N, Baek I, Song Y ACS Biomater Sci Eng. 2024; 10(10):6545-6557.

PMID: 39259933 PMC: 11480936. DOI: 10.1021/acsbiomaterials.4c01100.


Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery.

Baek I, Song Y J Vis Exp. 2024; (208).

PMID: 38912769 PMC: 11292835. DOI: 10.3791/66872.


Development of porcine skeletal muscle extracellular matrix-derived hydrogels with improved properties and low immunogenicity.

Barajaa M, Otsuka T, Ghosh D, Kan H, Laurencin C Proc Natl Acad Sci U S A. 2024; 121(19):e2322822121.

PMID: 38687784 PMC: 11087813. DOI: 10.1073/pnas.2322822121.


References
1.
Wood J, Simmons-Byrd A, Spievack A, Badylak S . Use of a particulate extracellular matrix bioscaffold for treatment of acquired urinary incontinence in dogs. J Am Vet Med Assoc. 2005; 226(7):1095-7. DOI: 10.2460/javma.2005.226.1095. View

2.
Badylak S, Vorp D, Spievack A, Simmons-Byrd A, Hanke J, Freytes D . Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res. 2005; 128(1):87-97. DOI: 10.1016/j.jss.2005.03.002. View

3.
Beattie A, Gilbert T, Guyot J, Yates A, Badylak S . Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng Part A. 2008; 15(5):1119-25. PMC: 2789572. DOI: 10.1089/ten.tea.2008.0162. View

4.
Robinson K, Li J, Mathison M, Redkar A, Cui J, Chronos N . Extracellular matrix scaffold for cardiac repair. Circulation. 2005; 112(9 Suppl):I135-43. DOI: 10.1161/CIRCULATIONAHA.104.525436. View

5.
Badylak S, Valentin J, Ravindra A, McCabe G, Stewart-Akers A . Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A. 2008; 14(11):1835-42. DOI: 10.1089/ten.tea.2007.0264. View